Status:
TERMINATED
Complementary and Alternative Interventions for Veterans With Posttraumatic Stress Disorder
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
The Dana Foundation
Conditions:
PTSD
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The overarching aim of this proposal is to research whether meditation-based treatments are effective in decreasing posttraumatic stress disorder (PSTD) symptoms in veterans, which complementary and a...
Detailed Description
The overarching purpose of this study is to assess the impact of CA interventions on posttraumatic stress symptoms in veterans with PTSD. Twenty percent of the approximately 2 million veterans returni...
Eligibility Criteria
Inclusion
- In the age range of 18-50.
- Capable of giving informed consent
- Fluent in English
- Exposure to one or more life-threatening war zone trauma events in Iraq or Afghanistan within the last 8 years.
- Pharmacological or psychotherapeutic treatment stable for at least 8 weeks prior to beginning of study
- Good general medical health (see Medical Exclusion Criteria)
- DSM-IV criteria for current PTSD as determined by CAPS (PTSD groups only)
- Combat-exposed, non-PTSD control veterans must be free of any current DSM-IV Axis I disorder
- Participants must agree to not begin a new course of treatment for the duration of the study
Exclusion
- Weight of 352 pounds or over (due to constraints of MRI scanner)
- Women who are pregnant, planning to conceive during the research timeline, or breastfeeding will be excluded.
- Metallic implants such as prostheses or aneurysm clip, or electronic implants such as cardiac pacemakers
- Neurological or serious medical condition that may contraindicate MRI or that may overlap with physiological substrates of psychiatric conditions (see below for descriptions)
- History of seizures or seizure disorder
- Moderate or severe traumatic brain injury (over 30 minutes unconscious)
- Current active substance dependence or dependence within 3 months (other than nicotine)
- Meets DSM-IV criteria for bipolar disorder, schizophrenia, schizoaffective disorder, psychotic disorder NOS, delirium, or any DSM-IV cognitive disorder.
- Substance dependence disorder within 3 months or any current substance dependence
- Severe psychiatric instability or severe situational life crises, including evidence of being actively suicidal or homicidal, or any behavior that poses an immediate danger to patient or others.
- Current use of benzodiazepines or beta-blockers
- Nonsuicidal depression comorbid with PTSD will NOT be exclusionary
- Extensive experience in yoga and meditation or have learned MBSR or SKY previously
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01512303
Start Date
April 1 2012
End Date
May 1 2013
Last Update
May 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Waisman Center, University of Wisconsin
Madison, Wisconsin, United States, 53705